DEVICE: MDx-Chex for BC-GP (00844509002468)
Device Identifier (DI) Information
MDx-Chex for BC-GP
250079
In Commercial Distribution
250079
STRECK, INC.
250079
In Commercial Distribution
250079
STRECK, INC.
MDx-Chex™ for BC-GP is intended for use as an external positive and negative assayed control to monitor the
performance of the qualitative detection of Gram-positive bacteria and associated antimicrobial resistance
genes, by the Luminex VERIGENE® Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on Luminex
VERIGENE® systems. The MDx-Chex™ for BC-GP Positive and Negative Controls are composed of a buffered
solution with stabilized erythrocytes and leukocytes in a matrix of blood culture media components.
Positive Control: Gram-positive bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus
lugdunensis, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecalis,
Enterococcus faecium, Streptococcus anginosus group; Species: Staphylococcus spp., Streptococcus spp., Listeria spp.;
antimicrobial resistance genes: mecA, vanA and vanB. Negative Control: buffered solution only. This product
is not intended to replace manufacturer controls provided with the device.
Device Characteristics
Labeling does not contain MRI Safety Information | |
No | |
No | |
No | |
Yes | |
No | |
Yes | |
No | |
No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
---|---|---|---|---|
61314 | Multiple-type bloodstream pathogen nucleic acid IVD, control |
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of nucleic acids and/or genes conferring antimicrobial resistance from multiple types of microorganisms associated with bloodstream infection (i.e., bacteria, fungi, and viruses) in a clinical specimen and/or culture isolate.
|
Active | false |
FDA Product Code
[?]Product Code | Product Code Name |
---|---|
PMN | Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays |
FDA Premarket Submission
FDA Premarket Submission Number [?] | Supplement Number [?] |
---|---|
Premarket Submission Number Not Available/Not Released |
Sterilization
Storage and Handling
[?]Storage and Handling |
---|
No storage/handling found |
Clinically Relevant Size
[?]Size Type Text |
---|
No Device Sizes |
Device Record Status
627324f4-a695-4931-b1a6-9884012595f6
August 17, 2023
1
August 09, 2023
August 17, 2023
1
August 09, 2023
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
---|---|---|---|---|---|
No Package DIs found |
Secondary DI
[?]Issuing Agency [?] | Secondary DI Number |
---|---|
No Secondary DIs found |
Unit of Use DI
[?]
Unit of Use DI Number:
No Unit of Use DI Numbers Found
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
No Customer Contact currently defined